AIA forces changes in invention capture and review procedures: study

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

AIA forces changes in invention capture and review procedures: study

The America Invents Act has prompted many companies to make changes in their invention capture and review procedures and public disclosure polices, according to a study released by IP advisory firm ipPerformance

Compared to study results released in 2012 before implementation of the AIA, roughly double the companies indicated that they made changes in invention capture and submission stage versus their preparation and filing stage.

Some 85% of companies indicated that the AIA has influenced them to make public disclosure of an invention prior to patent filing policy changes. A third of companies indicated that the increase in USPTO fees will cause an increase to their patent budget.

“America Invents Act has encouraged companies to adapt their procedures, workflows and policies. The increased fees as well as pre and post grant proceedings are major factors that are impacting budgeting and strategy,” said Robert Williamson, president at ipPerformance Group.

Fifty-nine companies representing a variety of industries participated in the study, including Air Liquide, Nova Chemical, Sun Chemical, Dow Corning Corporation, Nova Measuring Instruments, ZBD, Avebe, Sasol, Neste Oil, Micro Encoder, Automotive Technologies and Freescale Semiconductor.

more from across site and SHARED ros bottom lb

More from across our site

Despite being outspent by a wealthy opponent, a trial attorney at King & Spalding says ‘relentless pursuit of the truth’ helped his team secure a $420m damages award for mobile gaming client
190 drugs face loss of exclusivity between 2026 and 2030, with the list including Bristol Myers Squibb’s blood-thinning drug Eliquis and immunotherapy medication Opdivo
Nokia, represented by a team from Bird & Bird, adjudged to have made fair offer to Asus and Acer in UK SEP dispute
Azhar Sadique and Kane Ridley, who founded the London office in 2023, are now both working in legal tech and AI-related roles, while another UK-based lawyer has also left
Partner Pierre Pérot rejoins the firm he left in 2022 alongside another returning lawyer, associate Camille Abba
Vaping dispute, in which Stobbs and Brandsmiths are the representatives, tested how the UK's Human Rights Act can apply to injunctions restraining unjustified threats
An AI platform being sold for £40m, and lateral hires involving law firms Womble Bond Dickinson and Cadwell Thomas were among the top talking points
With the London Annual Meeting behind us, we look back at some of the lessons learned this week and ahead to what 2027 will bring
In-house counsel aren’t impressed with law firms’ international networks, but practitioners say they are crucial for business
Publication of the UPC’s annual report and adoption of the procedural rules of the Patent Mediation and Arbitration Centre were also among major developments
Gift this article